作为医疗投资专家,王翔宇凭借敏锐的市场洞察力、杰出的并购整合能力和稳健的投资策略,在医疗器械领域屡创佳绩。他通过创新估值方法和投资模式,成功投资迈瑞医疗并主导跨境并购SafeHeal等项目,未来还将推动全球医疗行业的创新发展。■ 本刊记者/ 赵镜从领投A股上市最大的医疗器械公司深圳迈瑞,到成功并购中国抗菌医用缝线领头企业华尔康,再到跨境投资法国创新结直肠覆膜支架公司SafeHeal,王翔宇以他敏锐...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.